What are Harmony Biosciences Holdings, Inc.'s profit margins?

Gross margin is 76.5% and operating margin is 21.1%, with a 16.2% net margin.

Where does Harmony Biosciences Holdings, Inc.'s income statement data come from?

Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Harmony Biosciences Holdings, Inc. HRMY Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$899.11M+3.5%	$868.45M+5.1%	$825.94M+6.9%	$772.53M+3.7%	$744.85M+4.2%
Total cost of revenue	$210.86M+6.3%	$198.34M+7.7%	$184.21M+10.1%	$167.33M+3.7%	$161.33M+2.9%
Gross profit	$688.25M+2.7%	$670.11M+4.4%	$641.74M+6.0%	$605.19M+3.7%	$583.53M+4.6%
Gross margin	76.5%-0.6pp	77.2%-0.5pp	77.7%-0.6pp	78.3%0.0pp	78.3%+0.3pp
Research and development	$224.44M+18.4%	$189.59M+8.8%	$174.33M+20.4%	$144.75M-8.5%	$158.18M+8.5%
Selling and marketing	$120.5M+0.8%	$119.51M+1.3%	$117.93M+1.7%	$115.96M+1.4%	$114.39M+3.1%
General and administrative	$153.8M+0.8%	$152.54M+23.2%	$123.84M+1.0%	$122.62M+5.8%	$115.92M+5.0%
Total operating expenses	$498.73M+8.0%	$461.64M+10.9%	$416.1M+8.5%	$383.33M-1.3%	$388.49M+5.8%
Operating income	$189.52M-9.1%	$208.47M-7.6%	$225.64M+1.7%	$221.86M+13.8%	$195.04M+2.2%
Operating margin	21.1%-2.9pp	24%-3.3pp	27.3%-1.4pp	28.7%+2.5pp	26.2%-0.5pp
Interest expense	$14.05M-4.1%	$14.65M-4.3%	$15.31M-4.5%	$16.04M-4.5%	$16.8M-4.0%
Other income (expense), net	-$531K+21.9%	-$680K—	——	——	——
Income before income taxes	$197.57M-8.1%	$215.06M-6.7%	$230.46M+2.4%	$225.14M+14.2%	$197.2M+2.8%
Income tax expense	$51.96M-7.8%	$56.38M+25.9%	$44.78M+1.2%	$44.24M-0.5%	$44.48M-4.0%
Net income	$145.62M-8.2%	$158.69M-14.5%	$185.68M+2.6%	$180.9M+18.5%	$152.72M+5.0%
Net margin	16.2%-2.1pp	18.3%-4.2pp	22.5%-0.9pp	23.4%+2.9pp	20.5%+0.1pp
Diluted earnings per share	$2.49-8.5%	$2.72-14.5%	$3.18+2.6%	$3.10+18.3%	$2.62+4.4%
EBITDA	$213.38M-8.2%	$232.33M-6.9%	$249.51M+1.5%	$245.73M+12.2%	$218.99M+1.9%
EBITDA margin	23.7%-3.0pp	26.8%-3.5pp	30.2%-1.6pp	31.8%+2.4pp	29.4%-0.7pp
EBIT	$189.52M-9.1%	$208.47M-7.6%	$225.64M+1.7%	$221.86M+13.8%	$195.04M+2.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Harmony Biosciences Holdings, Inc.'s profit margins?: Gross margin is 76.5% and operating margin is 21.1%, with a 16.2% net margin.
Where does Harmony Biosciences Holdings, Inc.'s income statement data come from?: Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.